Oxytrol for Women becomes first OAB remedy now available OTC

WHITEHOUSE STATION, N.J. — Merck Consumer Care on Wednesday announced that Oxytrol for Women is now on shelf for the more than 20 million women suffering from overactive bladder. Oxytrol for Women is a thin, flexible patch that is discreetly applied to the abdomen, hip or buttock once every four days for the relief of overactive bladder in women. It is the first and only over-the-counter option that treats the OAB symptoms — urinary incontinence, urgency and frequency — which can take a physical and emotional toll on women.

"It’s important for women to have access to a prescription-strength OTC option like Oxytrol for Women because it offers them a convenient and cost-effective way to help manage their condition," stated Eman Elkadry, spokesperson for Merck Consumer Care. "Women who suffer from OAB wait on average more than three years before seeking care."

With an OTC option in hand and a lifestyle modification plan, female OAB sufferers can gain better control over OAB symptoms. By applying one patch every four days as directed, Oxytrol for Women can provide women OAB symptom relief within two weeks when combined with daily lifestyle changes. These modifications include following a daily bathroom schedule, managing fluid intake and strengthening bladder muscles. Maintaining a healthy weight can also help, as excess weight can increase the pressure on the bladder and make OAB worse. The Oxytrol for Women patch can be worn during everyday activities, including showering or exercising.

“Merck is proud to bring a first-in-class, over-the-counter OAB product for women to shelves nationwide,” commented James Mackey, SVP and U.S. Region head for Merck Consumer Care. “Leveraging our prescription-to-OTC switch experience to deliver greater access and value is another example of how Merck is committed to enhancing the quality of life for women.”

Get connected and follow us on LinkedIn for the most in-depth coverage of drug store news. Join the conversation.